Uncategorized

Biotech company Regeneron to buy bankrupt 23andMe for $256M – Ars Technica

Posted on Author Tim Hodges Comments Off on Biotech company Regeneron to buy bankrupt 23andMe for $256M – Ars Technica
  1. Biotech company Regeneron to buy bankrupt 23andMe for $256M  Ars Technica
  2. Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million  CNN
  3. 23andMe to Be Bought by Biotech Company for $256 Million  The New York Times
  4. Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million  WSJ
  5. Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale  GlobeNewswire